Aiming Low On Product Recalls Draws FDA Concern – Experts
This article was originally published in The Tan Sheet
Executive Summary
Drug and supplement firms should prepare detailed recall strategies and should not aim low on product volume when they conduct recalls, according to an FDA official and an industry consultant
You may also be interested in...
FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down
FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills
FLAVORx Hopes A Spray-Full Of Pill Glide Helps The Medicine Go Down
FLAVORx designed its flavored Pill Glide Swallowing Sprayto help consumers take difficult-to-swallow or unpleasant-tasting pills
Senate Exempts Supplements From Redundant Regs; Suppliers Left Hanging
Food safety reform bill does not similarly exclude ingredient suppliers, who would presumably be subject to hazard analysis and critical control point-like rules.